Heyu Biological Technology (HYBT) Stock Price, News & Analysis

Company Overview

Hong Chang Biotechnologies (HK) Limited was incorporated in 2023 and is based in Kowloon, Hong Kong. Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Zengqiang Investment Limited. As of September 4, 2023, Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Heyu Biological Technology Corporation.

Key Stats

• Today's Range: $0.27 to $0.27
• 50-Day Range: $0.20 to $0.30
• 52-Week Range: $0.00 to $3.40
• Volume: N/A
• Average Volume: 5,371 shs
• Market Capitalization: $27.88 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

HYBT Stock Analysis - Frequently Asked Questions

How have HYBT shares performed this year?

Heyu Biological Technology's stock was trading at $0.3488 at the start of the year. Since then, HYBT shares have decreased by 22.6% and is now trading at $0.27.
View the best growth stocks for 2024 here.

When did Heyu Biological Technology's stock split?

Shares of Heyu Biological Technology reverse split on Monday, August 14th 2023. The 1-10 reverse split was announced on Monday, August 14th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, August 14th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

How do I buy shares of Heyu Biological Technology?

Shares of HYBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Today: 9/20/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Computer and Technology
• Industry: Electromedical equipment
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:HYBT
• CUSIP: N/A
• CIK: 1086303
• Web: heyubt.com
• Phone: 8615859240902
• Fax: 858-459-1103
• Employees: 6
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-270,000.00
• Net Margins: -453.55%
• Pretax Margin: -449.84%
• Return on Equity: -6.43%
• Return on Assets: -4.43%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.35
• Quick Ratio: 0.34

Sales & Book Value

• Annual Sales: $80,000.00
• Price / Sales: 348.46
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.38 per share
• Price / Book: 0.71

Miscellaneous

• Outstanding Shares: 103,247,000
• Free Float: 11,109,000
• Market Cap: $27.88 million
• Optionable: Not Optionable
• Beta: -17.74